CAPRICOR THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.68 USD | +2.34% |
|
-5.18% | +16.16% |
| May. 17 | Oppenheimer Initiates Capricor Therapeutics at Outperform Rating | MT |
| May. 13 | Transcript : Capricor Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024 |
Chart calendar Capricor Therapeutics, Inc.
50db37276374817f0cbb87cf54e.etTyWdMzfEyzUZ_gxw82vaL7mHYkSjBDD1S-eVpZtNQ.A7-eAIZlJSmDMO6Pn1Vc3_qj8DUVLHMxVzvyNmkP5uwOmbk_sR4aLednzg~50e46972584bdf0a22044a5f0b54445d
Upcoming events on Capricor Therapeutics, Inc.
Past events on Capricor Therapeutics, Inc.
| 2024-05-28 | Society for Cell & Gene Therapy International Meeting |
| 2024-05-22 | CureDuchenne FUTURES National Conference |
| 2024-05-14 01:00 pm | Annual General Meeting |
| 2024-05-13 04:30 pm | Q1 2024 Earnings Call |
| 2024-05-13 04:05 pm | Q1 2024 Earnings Release |
| 2024-05-08 | Society of Extracellular Vesicles International Meeting |
| 2024-05-06 | American Society of Gene & Cell Therapy Meeting |
| 2024-04-29 08:30 am | CAP-1002 DMD Update Call |
| 2024-04-03 01:30 pm | Cantor Fitzgerald Muscular Dystrophy Symposium |
| 2024-03-26 02:00 pm | H.C. Wainwright Cell Therapy Virtual Conference |
| 2024-03-06 11:45 am | MDA Clinical and Scientific Conference |
| 2024-02-29 04:30 pm | Q4 2023 Earnings Call |
| 2024-02-29 04:05 pm | Q4 2023 Earnings Release |
| 2023-11-14 04:30 pm | Q3 2023 Earnings Call |
| 2023-11-14 04:05 pm | Q3 2023 Earnings Release |
| 2023-10-25 01:00 pm | Business Update Call |
| 2023-10-10 | Cell & Gene Meeting on the Mesa Conference |
| 2023-10-06 03:30 pm | World Muscle Society International Congress |
| 2023-09-29 08:30 am | Business Update Call |
| 2023-08-07 04:30 pm | Q2 2023 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,01 0,84 19.43% | 0,31 0,25 23.12% | 0,24 0,22 10.07% | 2,55 1,60 59.87% | 25,2 21,0 19.64% | 26,6 |
|
EBITDA Million USD | Released Forecast Spread | -7,73 -8,40 7.93% | 0,00 0,00 - | -20,9 -19,4 -7.93% | -29,2 -30,1 3.11% | -22,8 -30,4 25.03% | -42,8 |
|
EBIT Million USD | Released Forecast Spread | -7,73 -8,26 6.39% | -13,7 -13,5 -1.26% | -20,9 -19,2 -9.1% | -29,7 -30,2 1.56% | -23,9 -28,1 15.08% | -34,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -7,64 -8,17 6.5% | -13,7 -13,5 -1.25% | -20,0 -18,3 -9.24% | -29,0 -29,8 2.49% | -22,3 -26,6 16.21% | -33,7 |
|
Net income Million USD | Released Forecast Spread | -7,64 -8,17 6.5% | -13,7 -13,5 -1.25% | -20,0 -18,3 -9.24% | -29,0 -29,8 2.49% | -22,3 -26,6 16.2% | -33,7 |
|
EPS USD | Released Forecast Spread | -2,06 -1,97 -4.83% | -0,88 -0,88 0% | -0,87 -0,80 -8.75% | -1,18 -1,22 3.01% | -0,83 -1,04 20.19% | -1,04 |
| Announcement Date | 18/03/20 | 11/03/21 | 10/03/22 | 15/03/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | December | 2020 S1 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,24 0,43 -45.22% | 0,00 0,20 - | 1,59 0,14 1036.84% | 0,96 0,01 19098% | 2,99 0,50 497.34% | 3,92 1,60 144.84% | 6,19 3,17 95.44% | 12,1 7,95 52.05% | 4,91 9,70 -49.41% | 4,58 | 4,48 | 12,6 | 0,00 | 0,00 | |
|
EBITDA Million USD | Released Forecast Spread | -7,32 -6,00 -22.03% | -6,48 -7,00 7.46% | -7,87 -8,50 7.36% | -7,95 -8,00 0.57% | -7,49 -8,60 12.88% | -0,76 -7,60 90.06% | -3,60 | -11,4 | -11,7 | -9,50 | |||||
|
EBIT Million USD | Released Forecast Spread | -7,32 -7,07 -3.55% | -6,48 -7,85 17.49% | -8,07 -8,57 5.9% | -8,18 -9,27 11.7% | -7,75 -8,98 13.71% | -6,86 -9,33 26.41% | -1,06 4,31 -124.68% | -10,3 -3,81 -169.66% | -10,3 | -10,6 | -0,95 | -12,1 | -12,1 | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -7,11 -7,07 -0.54% | -6,37 -7,47 14.67% | -7,72 -8,49 9.06% | -7,77 -8,39 7.46% | -7,37 -8,73 15.62% | -6,39 -9,15 30.12% | -0,76 -5,06 84.94% | -9,79 -3,48 -181.28% | -10,2 | -10,7 | -2,89 | -12,1 | -12,1 | ||
|
Net income Million USD | Released Forecast Spread | -7,11 -7,07 -0.54% | -6,37 -7,47 14.67% | -7,72 -8,49 9.06% | -7,77 -8,39 7.46% | -7,37 -8,73 15.62% | -6,39 -9,15 30.12% | -0,76 -5,06 84.94% | -9,79 -3,48 -181.28% | -10,2 | -10,7 | -2,89 | -12,1 | -12,1 | ||
|
EPS USD | Released Forecast Spread | -0,32 | -0,29 -0,26 -13.73% | -0,26 -0,31 15.22% | -0,31 -0,34 8.82% | -0,31 -0,32 3.13% | -0,29 -0,35 16.35% | -0,25 -0,30 17.58% | -0,02 -0,20 89.74% | -0,31 -0,11 -173.54% | -0,32 | -0,33 | -0,08 | -0,31 | -0,31 | |
| Announcement Date | 06/08/20 | 10/05/22 | 10/08/22 | 10/11/22 | 15/03/23 | 11/05/23 | 07/08/23 | 14/11/23 | 29/02/24 | 13/05/24 | - | - | - | - | - |
More events
Past sector events for Capricor Therapeutics, Inc.
| 2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 08:00 am | IMMUNOME, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CAPR Stock
- Calendar Capricor Therapeutics, Inc.
